Key Market Indicators
Germany's hypnotic and sedative medicine sales are projected to hit $80.75 million by 2026. This is a slight decrease from 2021, when sales totaled $95.7 million - a 2.4% drop from the previous year. Since 1991, hypnotic and sedative medicines sales in Germany have been on the decline, dropping 0.9% each year on average. As of 2021, Canada overtook the country in sales, with Germany, Sweden, and Belgium ranking second, third, and fourth, respectively.
